Company filings profile · CIK 0001937993

Cadrenal Therapeutics, Inc. — SEC filings & insider activity.

Real, source-linked SEC EDGAR activity for Cadrenal Therapeutics, Inc. (CVKD): 24 filings in the last 90 days vs 8 in the prior 90 (filing-velocity rising ↑ · 3×). Latest material 8-K events, insider Form-4 transactions, and periodic reports — monitored for change.

✔ Verified against the public SEC EDGAR filing record as of Jun 21, 2026. Source-linked, daily-refreshed.

Material 8-K events — Cadrenal Therapeutics, Inc.

8-K disclosures decoded by item code (the material events: agreements, results, control/management changes, impairments, restatements).

FiledEvent
Jun 18, 2026Regulation FD Disclosure; Other Events; Financial Statements and Exhibits
Jun 3, 2026Departure/Election of Directors or Officers; Financial Statements and Exhibits
May 7, 2026Results of Operations (earnings); Financial Statements and Exhibits
Apr 30, 2026Regulation FD Disclosure; Other Events; Financial Statements and Exhibits
Apr 1, 2026Entry into a Material Agreement; Unregistered Sale of Securities; Item 3.03; Financial Statements and Exhibits
Mar 31, 2026Results of Operations (earnings); Financial Statements and Exhibits
Mar 12, 2026Regulation FD Disclosure; Other Events; Financial Statements and Exhibits
Feb 24, 2026Other Events; Financial Statements and Exhibits
Dec 23, 2025Other Events; Financial Statements and Exhibits
Dec 16, 2025Entry into a Material Agreement; Unregistered Sale of Securities; Financial Statements and Exhibits
Dec 11, 2025Entry into a Material Agreement; Regulation FD Disclosure; Other Events; Financial Statements and Exhibits

Watch Cadrenal Therapeutics, Inc. automatically

Add this company to a watchlist and get a webhook/email the moment it files a material 8-K, an insider Form 4, or changes its risk-factor language.

Insider transactions (Form 4 / 3 / 5)

FiledForm
Jun 18, 20264
Jun 15, 20264
Jun 10, 20264
Jun 5, 20264
Jun 2, 20264
May 29, 20264
May 26, 20264
Dec 31, 20254
Dec 3, 20254
Dec 3, 20253
Oct 28, 20254
Oct 28, 20254
Oct 14, 20254
Oct 14, 20254
Oct 7, 20254
Oct 3, 20254

Recent filings

FiledFormDetail
Jun 18, 20264
Jun 18, 20268-K Regulation FD Disclosure; Other Events; Financial Statements and Exhibits
Jun 15, 20264
Jun 15, 2026144
Jun 10, 20264
Jun 5, 20264
Jun 3, 20268-K Departure/Election of Directors or Officers; Financial Statements and Exhibits
Jun 2, 20264
May 29, 20264
May 26, 20264
May 11, 2026144
May 7, 20268-K Results of Operations (earnings); Financial Statements and Exhibits
May 7, 202610-Q QUARTERLY REPORT
Apr 30, 20268-K Regulation FD Disclosure; Other Events; Financial Statements and Exhibits
Apr 29, 2026EFFECT Item ; Item ; Item
Apr 29, 2026424B3 PROSPECTUS
Apr 27, 2026CORRESP
Apr 27, 2026UPLOAD
Apr 21, 2026S-3 REGISTRATION STATEMENT
Apr 6, 2026D Item 06b
Apr 1, 20268-K Entry into a Material Agreement; Unregistered Sale of Securities; Item 3.03; Financial Statements and Exhibits
Apr 1, 2026424B5 PROSPECTUS SUPPLEMENT
Mar 31, 202610-K ANNUAL REPORT
Mar 31, 20268-K Results of Operations (earnings); Financial Statements and Exhibits
Mar 12, 20268-K Regulation FD Disclosure; Other Events; Financial Statements and Exhibits
Feb 24, 20268-K Other Events; Financial Statements and Exhibits
Jan 2, 2026424B3 PROSPECTUS
Dec 31, 2025EFFECT Item ; Item ; Item
Dec 31, 2025D Item 06b
Dec 31, 20254
Dec 29, 2025144
Dec 29, 2025S-1 REGISTRATION STATEMENT
Dec 23, 20258-K Other Events; Financial Statements and Exhibits
Dec 23, 2025424B5 PROSPECTUS SUPPLEMENT
Dec 16, 20258-K Entry into a Material Agreement; Unregistered Sale of Securities; Financial Statements and Exhibits
Dec 16, 2025424B5 PROSPECTUS SUPPLEMENT
Dec 16, 2025424B5 PROSPECTUS SUPPLEMENT
Dec 11, 20258-K Entry into a Material Agreement; Regulation FD Disclosure; Other Events; Financial Statements and Exhibits
Dec 3, 20254
Dec 3, 20253